Navigation Links
Salivary Test Could Predict Future Oral Bone Loss

Researchers at the University at Buffalo have been able to identify two key components in saliva that could be used to predict the amount of oral bone loss in future. Oral bone loss is detrimental for teeth since the bone around a tooth is vital to hold it in place. //

Researchers compared the dental x-rays of more than a 100 patients and related them with the levels of salivary proteins. It was found that IL-1-beta levels were higher in patients with considerable bone loss. Another protein osteonectin was found to have an inverse relation to bone loss. "These results show that above-average levels of IL-1 beta in saliva may prove to help the dentist decide whether or not to treat the dental patient for periodontal disease," said lead researcher Frank Scannapieco, D.D.S., Ph.D., professor and chair of the Department of Oral Biology in the UB dental school. The results of the research were presented at the annual meeting of the International Association of Dental Research. "We can measure gum pocket depth, or the amount of bone remaining on an X-ray, but these methods only tell us how much damage already has been done. This biomarker test also could provide a quick and easy way to monitor patients over the long-term and to determine if a particular treatment is working," Scannapieco said.

Patricia Yen Bee Ng, Maureen Donley, D.D.S., Ernest Hausmann, D.M.D., Ph.D., Alan Hutson, Ph.D., Jean Wactowski-Wende, Ph.D., and Paul Bronson. Edward Rossomando, Ph.D., from the University of Connecticut were the other reserachers that contributed to the study. National Institute of Dental and Craniofacial Research supported the study.
'"/>




Page: 1

Related medicine news :

1. Salivary Analysis for Early Detection of Breast Cancer
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Nasal Spray Could Take Drugs Directly to Brain
5. Oxygen Usage During Exercise Could Indicate Heart Problems
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. Anger Could Be Linked To Weight Gain
8. A Seizure Late In Life Could be A Stroke Warning
9. New Findings Could Reduce The Extent Of Spinal Cord Injuries
10. Could There Be A Link Between Famine and Breast Cancer ?
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: